Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 7.16T | 7.14T | 6.40T | 5.52T | 4.94T |
Gross Profit | 1.10T | 1.09T | 1.40T | 1.26T | 1.12T |
EBITDA | 980.41B | 756.05B | 790.43B | 701.51B | 494.54B |
Net Income | 419.08B | 312.79B | 314.63B | 263.90B | 125.06B |
Balance Sheet | |||||
Total Assets | 8.13T | 9.09T | 7.41T | 7.43T | 6.77T |
Cash, Cash Equivalents and Short-Term Investments | 1.10T | 837.79B | 733.85B | 867.81B | 897.39B |
Total Debt | 699.38B | 850.72B | 943.64B | 1.05T | 910.65B |
Total Liabilities | 2.94T | 3.35T | 2.83T | 2.94T | 2.69T |
Stockholders Equity | 4.98T | 5.53T | 4.38T | 4.30T | 3.89T |
Cash Flow | |||||
Free Cash Flow | 313.32B | 515.42B | 188.41B | 23.49B | 2.55B |
Operating Cash Flow | 758.74B | 961.83B | 602.72B | 395.64B | 437.24B |
Investing Cash Flow | 121.90B | -459.49B | -363.68B | -301.58B | -395.90B |
Financing Cash Flow | -677.43B | -496.66B | -400.10B | -159.54B | 238.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $15.08B | 11.48 | 15.52% | ― | -2.47% | -43.12% | |
79 Outperform | $3.02B | 10.37 | 25.15% | ― | -1.35% | -39.06% | |
76 Outperform | $7.87B | 28.79 | 5.38% | 1.23% | -8.23% | -52.61% | |
75 Outperform | $9.10B | 13.55 | 28.71% | 2.38% | -2.29% | 35.00% | |
74 Outperform | $5.70B | 12.49 | 10.00% | 2.89% | -3.15% | -6.70% | |
72 Outperform | $35.81B | 14.06 | 7.87% | 1.86% | -4.93% | 30.34% | |
63 Neutral | $16.85B | 11.25 | -7.01% | 2.93% | 1.72% | -24.85% |